Although high PI3K signaling is acknowledged as a characteristic cancer feature, abundant studies have revealed other unsuspected roles for the PI3K catalytic pathway in both physiological and pathological cell function (Fruman et al., 2017), which may help to reconcile the beneficial effects associated with PI3K inhibition with those related to PI3K activation described in the preceding paragraphs. Here, PIK3CG is linked to cancer.